| scholarly article | Q13442814 |
| P2093 | author name string | Factor SM | |
| van Hoeven KH | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 848-855 | |
| P577 | publication date | 1990-09-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease | |
| P478 | volume | 82 |
| Q37622130 | A Thin Left Atrial Antral Wall Around the Pulmonary Vein Reflects Structural Remodeling by Atrial Fibrillation and is Associated with Stroke |
| Q50531488 | A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension. |
| Q68146274 | Anatomical and functional cardiac abnormalities in type I diabetes |
| Q38113247 | Assessment and management of left ventricular hypertrophy in Type 2 diabetes patients with high blood pressure |
| Q35089822 | Association of micro albuminuria with diastolic function in obese normotensive no diabetic individuals |
| Q35166774 | Awareness, treatment and control of cardiometabolic disorders in Chinese adults with diabetes: a national representative population study |
| Q37004093 | Blood pressure reduction due to hemoglobin glycosylation in type 2 diabetic patients. |
| Q37699185 | Cardiac MRI evaluation of nonischemic cardiomyopathies |
| Q40476564 | Cardiac consequences of diabetes mellitus |
| Q35660804 | Cardiac remodeling in systemic hypertension |
| Q92435170 | Cardiac risk assessment for end-stage renal disease patients on the renal transplant waiting list |
| Q34451742 | Cardiomyopathy and heart failure in diabetes |
| Q43678508 | Cardiovascular structure and function in baboons with Type 1 diabetes -- a transvenous ultrasound study |
| Q53025217 | Causative role of coronary microvessels for the development and progression of chronic myocardial lesions in spontaneously hypertensive rats (SHR) |
| Q91669767 | Characterising an Alternative Murine Model of Diabetic Cardiomyopathy |
| Q46856995 | Characterization of alterations in diabetic myocardial tissue using high resolution MRI. |
| Q42258153 | Combination of a peroxisome proliferator-activated receptor-gamma agonist and an angiotensin II receptor blocker attenuates myocardial fibrosis and dysfunction in type 2 diabetic rats |
| Q72382552 | Comparison of echocardiographic variables between type I diabetics and normal controls |
| Q39393549 | Coronary microvascular dysfunction in diabetes mellitus |
| Q48408956 | Correlation between increased urinary sodium excretion and decreased left ventricular diastolic function in patients with type 2 diabetes mellitus. |
| Q58344631 | Determinants of Left Ventricular Hypertrophy and Diastolic Dysfunction in an HIV Clinical Cohort |
| Q59808766 | Diabetes and Arrhythmias: Pathophysiology, Mechanisms and Therapeutic Outcomes |
| Q36479405 | Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities |
| Q33711031 | Diabetes-induced alterations in the extracellular matrix and their impact on myocardial function |
| Q72189534 | Diabetic cardiomyopathy |
| Q38947643 | Diabetic cardiomyopathy: a clinical entity or a cluster of molecular heart changes? |
| Q38061830 | Diabetic cardiomyopathy: pathophysiological mechanisms and cardiac dysfuntion |
| Q30457504 | Diabetic cardiomyopathy: pathophysiology and clinical features |
| Q35184029 | Diabetic heart dysfunction: is cell transplantation a potential therapy? |
| Q58698191 | Dietary normalization from a fat, fructose and cholesterol-rich diet to chow limits the amount of myocardial collagen in a Göttingen Minipig model of obesity |
| Q36114162 | Disturbances in calcium metabolism and cardiomyocyte necrosis: the role of calcitropic hormones |
| Q73029315 | Echocardiographic detection of early diabetic myocardial disease |
| Q57504066 | Echocardiographic evaluation in type 1 diabetic patients on waiting list for isolated pancreas or kidney-pancreas transplantation |
| Q43828968 | Echocardiography in diabetic cardiomyopathy |
| Q33803815 | Effect of diabetes and hypertension on left ventricular diastolic function in a high-risk population without evidence of heart disease |
| Q43278202 | Effects of diabetes mellitus, pressure-overload and their association on myocardial structure and function |
| Q30535274 | Effects of type 1 diabetes mellitus on cardiac function: a study of monozygotic twins |
| Q33639278 | Evidence based cardiology: prevention of congestive heart failure and management of asymptomatic left ventricular dysfunction |
| Q36312605 | Excess protein O-GlcNAcylation and the progression of diabetic cardiomyopathy. |
| Q44249577 | Extracellular matrix maturation in the left ventricle of normal and diabetic swine |
| Q24644869 | Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers |
| Q73855123 | Fructose-3-phosphate production and polyol pathway metabolism in diabetic rat hearts |
| Q28251696 | GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes |
| Q41107253 | Heart disease in diabetes mellitus |
| Q73902309 | Heart failure in the elderly: a diastolic problem? |
| Q35207988 | High Sensitivity C - Reactive Protein is Associated with Diastolic Dysfunction in Young African Americans without Clinically Evident Cardiac Disease |
| Q52997785 | High-pass-filtered magnetocardiogram and cardiomyopathy in patients with type 1 diabetes mellitus. |
| Q41653529 | Hypertension and pathologic cardiovascular remodeling: a potential therapeutic role for T-type calcium antagonists |
| Q37861897 | Hypertension in diabetes: treatment considerations |
| Q50568386 | Impact of left ventricular longitudinal functional mechanics on the progression of diastolic function in diabetes mellitus. |
| Q35240672 | Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease |
| Q43689612 | Impact of type 2 diabetes on left ventricular geometry and diastolic function in hypertensive patients with chronic kidney disease. |
| Q37719325 | Impaired relaxation despite upregulated calcium-handling protein atrial myocardium from type 2 diabetic patients with preserved ejection fraction. |
| Q44702438 | Improvement in myocardial function by Terminalia arjuna in streptozotocin-induced diabetic rats: possible mechanisms. |
| Q49469496 | Increased left ventricular mass index is present in patients with type 2 diabetes without ischemic heart disease. |
| Q44190763 | Indapamide regresses, but transdermal clonidine does not regress, left ventricular hypertrophy in hypertensive diabetic patients |
| Q42869417 | Index of myocardial performance in patients with type 2 diabetes without hypertension and its relationship with clinical and echocardiographic parameters |
| Q48722498 | Influence of autonomic neuropathy upon left ventricular dysfunction in insulin-dependent diabetic patients |
| Q24800363 | Influence of diabetes mellitus on heart failure risk and outcome |
| Q52609028 | Intermittent hypoxia induces beneficial cardiovascular remodeling in left ventricular function of type 1 diabetic rat. |
| Q48794491 | Involvement of MicroRNAs in Diabetes and Its Complications |
| Q46620494 | Is there any relationship between metabolic parameters and left ventricular functions in type 2 diabetic patients without evident heart disease? |
| Q46439006 | Isolated type 2 diabetes mellitus causes myocardial dysfunction that becomes worse in the presence of cardiovascular diseases: results of the myocardial doppler in diabetes (MYDID) study 1. |
| Q39608627 | Late potentials: are they related to cardiovascular complications in children with type 1 diabetes? |
| Q99365610 | Left atrial stiffness index as a marker of early target organ damage in hypertension |
| Q36567763 | Left ventricular diastolic dysfunction in diabetic patients: pathophysiology and therapeutic implications |
| Q35590329 | Left ventricular diastolic dysfunction: an early sign of diabetic cardiomyopathy? |
| Q47274326 | Left ventricular size and function in patients with noninsulin-dependent diabetes and postinfarction total or subtotal coronary occlusions |
| Q30482680 | Management of chronic heart failure in the community: role of a hospital based open access heart failure service |
| Q46560683 | Mast Cells Play an Important Role in the Pathogenesis of Hyperglycemia-Induced Atrial Fibrillation |
| Q77291970 | Maternally transmitted susceptibility to non-insulin-dependent diabetes mellitus and left ventricular hypertrophy |
| Q89811716 | Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence |
| Q64111781 | Molecular Mechanisms Responsible for Diastolic Dysfunction in Diabetes Mellitus Patients |
| Q36836362 | Myocardial Fibrosis Quantified by Extracellular Volume Is Associated With Subsequent Hospitalization for Heart Failure, Death, or Both Across the Spectrum of Ejection Fraction and Heart Failure Stage |
| Q37371632 | Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. |
| Q34041355 | Myocardial infarction in women: a critical appraisal of gender differences in outcomes |
| Q36726217 | Myocardial involvement during the early course of type 2 diabetes mellitus: usefulness of myocardial performance index. |
| Q47113843 | New Antihyperglycemic Drugs and Heart Failure: Synopsis of Basic and Clinical Data. |
| Q74152203 | No evidence for systolic or diastolic left ventricular dysfunction at rest in selected patients with long-term type I diabetes mellitus |
| Q50626089 | Noninvasive assessment of left atrial phasic function in patients with hypertension and diabetes using two-dimensional speckle tracking and volumetric parameters. |
| Q95823849 | PPAR-γ receptor agonists-a review of their role in diabetic management in Trinidad and Tobago |
| Q39195672 | Pathophysiological Fundamentals of Diabetic Cardiomyopathy |
| Q36709180 | Pathophysiological effects of different risk factors for heart failure |
| Q44541867 | Patients with early diabetic heart disease demonstrate a normal myocardial response to dobutamine |
| Q46732505 | Plasma lipids, lipoproteins, and apolipoproteins in Nigerian diabetes mellitus, essential hypertension, and hypertensive-diabetic patients |
| Q30975367 | Preclinical diabetic cardiomyopathy: relation of left ventricular diastolic dysfunction to cardiac autonomic neuropathy in men with uncomplicated well-controlled type 2 diabetes |
| Q73290107 | QT dispersion in microalbuminuric Type 1 diabetic patients without myocardial ischemia |
| Q84020876 | Rapid quantification of myocardial fibrosis: a new macro-based automated analysis |
| Q46977102 | Relationship between parathyroid hormone and subclinical myocardial dysfunction in patients with severe psoriasis. |
| Q40847980 | Report of the Canadian Hypertension Society Consensus Conference: 5. Hypertension and diabetes |
| Q92268128 | Risk Factors Associated With Atrioventricular Block |
| Q36565055 | Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy |
| Q37924999 | Targeting fibrosis for the treatment of heart failure: a role for transforming growth factor-β. |
| Q38815425 | The Type 2 Diabetic Heart: Its Role in Exercise Intolerance and the Challenge to Find Effective Exercise Interventions |
| Q37514842 | The diabetic, hypertensive heart: epidemiology and mechanisms of a very high-risk situation |
| Q39275058 | The extracellular matrix in myocardial injury, repair, and remodeling. |
| Q43636295 | The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study |
| Q34278791 | The importance of age and obesity on the relation between diabetes and left ventricular mass |
| Q54409075 | The role of thrombospondin-1-mediated TGF-β1 on collagen type III synthesis induced by high glucose |
| Q36013015 | The use of metoprolol CR/XL in the treatment of patients with diabetes and chronic heart failure |
| Q36166429 | Type 2 diabetes mellitus: a cardiovascular perspective |
| Q37260494 | Type II diabetes promotes a myofibroblast phenotype in cardiac fibroblasts |
| Q48865131 | Ultrasound speckle tracking imaging contributes to early diagnosis of impaired left ventricular systolic function in patients with type 2 diabetes mellitus |
| Q36364062 | What role do extracellular matrix changes contribute to the cardiovascular disease burden of diabetes mellitus? |
| Q50922002 | [Clinical prediction of the early prognosis in acute myocardial infarct] |
| Q86268053 | [Perioperative care of patients with diastolic heart failure. Interface to anesthesia] |
Search more.